Clinical Trials Browser

Lenalidomide × Gastrointestinal × Clear all

NCT01352962 2026-04-14

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

Phase 1 Completed

GastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT04257448 2025-09-30

SEPION

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT07184424 2025-09-19

Lenalidomide

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT01547260 2022-08-22

LENAGEM

Phase 1/2 Completed

Gastrointestinal

Pancreatic Carcinoma Metastatic

NCT04326296 2020-05-15

The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer

Phase 1 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT01254617 2020-03-13

ADCC

Phase 1 Completed

GastrointestinalHead & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms

NCT00717756 2020-02-17

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

Phase 2 Completed

41 enrolled 6 charts

Gastrointestinal

Liver Neoplasms

NCT01545804 2017-02-09

Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01183663 2016-06-03

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Phase 1 Completed

BreastCNSDermatologicGastrointestinalGenitourinaryOther hematologic neoplasmPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT01348503 2015-08-31

Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma

Phase 1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular

NCT01032291 2013-05-21

A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer

Phase 2 Terminated

51 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms

NCT00837031 2013-03-13

Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas

Phase 2 Completed

72 enrolled 7 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01126450 2012-03-20

Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer

Phase 1 Terminated

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT01166035 2010-07-20

TEXO

Phase 1/2 Unknown

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms

NCT00179751 2005-11-07

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

Phase 1/2 Terminated

Gastrointestinal

Pancreatic Neoplasms